U.S. Markets close in 1 hr 17 mins

Tesaro Stock: What’s the Upside Potential?

Kenneth Smith
Tesaro Stock: What’s the Upside Potential?

Tesaro (TSRO) is a commercial stage biopharmaceutical company focused on developing treatments for solid tumors. Tesaro is licensed and developing a number of oncology-related product candidates. Of the 19 analysts covering Tesaro in May, 12 analysts gave the stock a “buy” or higher rating, while seven analysts gave a “hold” rating.